Trinity Biotech plc ã¯ãç±³åœãã¢ããªã«ãã¢ãžã¢ããšãŒãããã®èšºæåžå Žã®èšåºæ€æ»å®€ããã³ãã€ã³ããªãã±ã¢ (POC) ã»ã°ã¡ã³ãåãã®å»ç蚺æè£œåã®è²·åãéçºã補é ã販売ãè¡ã£ãŠããŸããå瀟ã¯ãã©ã€ã ç
ãæ¢
æ¯ããã«ãã¹ãªã©ã®æ§ææçãSARS-CoV-2ããšãã¹ã¿ã€ã³ã»ããŒã麻ç¹ããããµã颚éªããããœãã©ãºãçããµã€ãã¡ã¬ããŠã€ã«ã¹ã颚ç¹ãæ°Žçããã®ä»ã®ãŠã€ã«ã¹ç
åäœãªã©ã®ææçãæ€åºãã蚺æãã¹ããæ©åšãå«ãèšåºæ€æ»è£œåãããã³ç³å°¿ç
ã®ç£èŠãšèšºæãããã³ç³å°¿ç
ãçºçãããªã¹ã¯ã®ãã人ã®ç¹å®ã«äœ¿çšããããã¢ã°ããã³ A1c ã®äœå€èšºæãã¹ãçšã®è£œåãæäŸããŠããŸãããŸããå
ç«èå
ã¢ãã»ã€ãé
µçŽ çµåå
ç«åžçããŠãšã¹ã¿ã³ãããããã©ã€ã³å
ç«æž¬å®åœ¢åŒã®è£œåãéçºã補é ã販売ããŠããŸããèèç
ãè
èç
ãæº¶è¡æ§è²§è¡ã®èšºæã«çšãããã ACEãèæ±é
žãä¹³é
žãã·ã¥ãŠé
žãã°ã«ã³ãŒã¹ 6 ãªã³é
žããããã²ããŒãŒãªã©ã®è©Šè¬è£œåãæäŸããŠããŸãããŸããã©ã€ã ãµã€ãšã³ã¹æ¥çãç ç©¶æ©é¢ã«åææã販売ããŠããŸããå瀟ã¯ãèªç€Ÿã®çŽæ¥è²©å£²å¡ãç¬ç«è²©å£²æ¥è
ãæŠç¥çããŒãããŒã®ãããã¯ãŒã¯ãéããŠè£œåã販売ããŠããŸãã顧客ã«ã¯ãå
¬è¡è¡çæœèšãç
é¢ããã®ä»ã®ã¢ãŠããªãŒãæœèšãèšåºæ€æ»å®€ããªãã¡ã¬ã³ã¹æ€æ»å®€ãªã©ããããŸããTrinity Biotech plc 㯠1992 幎ã«èšç«ãããã¢ã€ã«ã©ã³ãã®ãã¬ã€ã«æ¬ç€Ÿã眮ããŠããŸãã